Optimization of rat liver microsomal stability assay using HPLC

Journal of Biological Sciences

Volumn 8, Issue 6, 2008, Pages 1110-1114

  Mondal, S K ^a   Mazumder, Upal Kanti ^a   Mondal, N B ^b   Benerjee, S ^b  

^a JADAVPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Drug metabolism; HPLC; Microsomal stability

Indexed keywords

ACETONITRILE; ANDROGRAPHOLIDE; ATENOLOL; DIMETHYL SULFOXIDE; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IMIPRAMINE; MAGNESIUM CHLORIDE; MIDAZOLAM; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROPRANOLOL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG METABOLISM; DRUG STABILITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; THERMOSTABILITY;

ANIMALIA; RATTUS;

EID: 60249091296     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2008.1110.1114     Document Type: Article

References (14)

1. de Waterbeemd, H., D.A. Smith, K. Beaumont and D.K. Walker, 2001. Property-based design: Optimization of drug absorption and pharmacokinetics. J. Med. Chem., 44: 1313-1333.
2. Di, L., E.H. Kerns, Y. Hong, T.A. Kleintop, O.J. McConnell and D.M. Huryn, 2003. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates. J. Biomol. Screen., 8: 453-462.
3. Giuliano, C., M. Jairaj, C.M. Zafiu and R. Laufer, 2005. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay. Drug Metab. Dispos., 33: 1319-1324.
4. Hasegawa, A., Y. Kawaguchi, H. Nakasa, H. Nakamura, S. Ohmori, I. Ishii and M. Kitada, 2002. Effects of Kampo extracts on drug metabolism in rat liver microsomes: Rhei Rhizoma extract and Glycyrrhizae Radix extract inhibit drug oxidation. Jap. J. Pharmacol., 89: 164-170.
5. Ito, K. and J.B. Houston, 2004. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm. Res., 21: 785-792.
6. Jenkins, K.M., R. Angeles, M.T. Quintos, R. Xu, D.B. Kassel and R.A. Rotrick, 2004. Automated high throughput ADME. assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries. J. Pharm. Biomed. Anal., 34: 999-1004.
7. Li, A.P., 2004. In vitro approaches to evaluate ADMET drug properties. Curr. Top. Med. Chem., 4: 701-706.
8. Lin, J.H. and A.D. Rodrigues, 2001. In vitro models for early studies of drug metabolism. In: Pharmacokinetic optimization in Drug research: Biological, Physicochemical and computational strategies. Testa, B., H. Van De Waterbeemd, G. Folkers and R. Guy (Eds.). Verlag Helvetica Chimica Acta, Switzerland, ISBN-10: 3-906390-22-5 pp: 217-243.
9. Linget J.M. and P.D. Vignaud, 1999. Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler. J. Pharm. Biomed. Anal., 19: 893-901.
10. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
11. Matsuda, T., M. Kuroyanagi, S. Sugiyama, K. Umehara, A. Ueno and K. Nishi, 1994. Cell Differentiation-inducing diterpenes from Andrographis paniculata nees. Chem. Pharm. Bull., 42:1216-1225.
12. Sinko, P.J., 1999. Drug selection in early drug development: Screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches. Curr. Opin. Drug Disc. Dev., 2: 42-48.
13. Trubetskoy, O.V., J.R. Gibson and B.D. Marks, 2005. Highly miniaturized formats for in vitro drug metabolism assays using vivid® fluorescent substrates and recombinant human cytochrome P450 enzymes. J. Biomol. Screen., 10: 56-66.
14. Xu, R, C. Nemes, K.M. Jenkins, R.A. Rourick, D.B. Kassel and C.Z.C. Liu, 2002. Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries. J. Am. Soc. Mass Spectrom. 13: 155-165.